ASX:PME

Update 24/11:

Update 20/11:

Is above the 10-day average and a stop loss should be in place at $247.05.

Pro Medicus

Update 12/11: Buy with the stop loss at $250

Add to your watchlist and wait for a close above the 10-day average.

Pro Medicus

Update 12/11: Buy with the stop loss at $250

Add to your watchlist and wait for a close above the 10-day average.

Pro Medicus

Update 12/11: Buy with the stop loss at $250

Add to your watchlist and wait for a close above the 10-day average.

Pro Medicus

Add to your watchlist and wait for a close above the 10-day average.

Pro Medicus Add to you watchlist

Pro Medicus

Pro Medicus’ profit jumped 42.7 per cent in the half-year to December after the company won and renewed several key contracts.

Profit rose to a record $51.7 million, while revenue rose by almost one-third to a record $97.2 million.

Pro Medicus is among the best growth companies on the ASX.

Revenue from contracts with customers for the 6-month period increased from $56.89m to $74.11m, an increase of 30.3%.

The Company reported a first-half after-tax profit of $36.25m, an increase of $9.06m (up 33.3%) compared to the same period last year

Sorry, but this content is restricted to our members.

Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.

If you are having an issue with your account, then please get in touch with us.

Pro Medicus is up 100% since the buy signal back in July 2020.

While the stock trades on a very high multiple 100x FY22 earnings, the 40%+ revenue and profit growth is supported by long-term contract wins. Watch for buying interest to build within the range indicated.

Pro Medicus is up 100% since the buy signal back in July 2020.

While the stock trades on a very high multiple 100x FY22 earnings, the 40%+ revenue and profit growth is supported by long-term contract wins. Watch for buying interest to build within the range indicated.